Drug Database
Back to search

Netherlands· NL-63f037ded51a

Efavirenz/ Emtricitabine/ Tenofovirdisoproxil Aurobindo 600 mg/200 mg/245 mg, filmomhulde tabletten

A emtricitabine, tenofovir disoproxil and efavirenz product containing efavirenz + emtricitabine + tenofovirdisoproxilfumaraat, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEfavirenz/ Emtricitabine/ Tenofovirdi…ATCJ05AR06REGISTER NO.NL-63f037ded51aPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about efavirenz + emtricitabine + tenofovirdisoproxilfumaraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine, tenofovir disoproxil and efavirenz is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR06 (emtricitabine, tenofovir disoproxil and efavirenz), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search emtricitabine, tenofovir disoproxil and efavirenz products by name

Emtricitabine, tenofovir disoproxil and efavirenz · ATC J05AR06

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
EFAVIRENZ + EMTRICITABINE + TENOFOVIRDISOPROXILFUMARAAT
Manufacturer
Aurobindo Pharma B.V.
Country
Netherlands (NL)
ATC code
J05AR06
ATC class
Emtricitabine, tenofovir disoproxil and efavirenz
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    123916

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for emtricitabine, tenofovir disoproxil and efavirenz.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check emtricitabine, tenofovir disoproxil and efavirenz against other medicinesHow interaction checks work

Emtricitabine, tenofovir disoproxil and efavirenz · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under J05AR06

Emtricitabine, tenofovir disoproxil and efavirenz, as other registers publish it.

All emtricitabine, tenofovir disoproxil and efavirenz products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed9b447e-86ab-491c-a62a-4a78d44a8a54
GET /v1/drugs/ed9b447e-86ab-491c-a62a-4a78d44a8a54?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h123916_smpc.pdf",
  "strength": null,
  "atc_label": "Emtricitabine, Tenofovir Disoproxil And Efavirenz",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg123916",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "EFAVIRENZ",
    "EMTRICITABINE",
    "TENOFOVIRDISOPROXILFUMARAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h123916.pdf",
  "authorised_at": "2020/01/09",
  "procedure_number": "PT/H/1955/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "123916",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about emtricitabine, tenofovir disoproxil and efavirenz.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console